| 395 |
228: demethylation, PPARg promoter |
408: reduction in ovarian granulosa cells, Aromatase (Cyp19a1) |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 411 |
228: demethylation, PPARg promoter |
54: Up Regulation, CD36 |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 487 |
228: demethylation, PPARg promoter |
457: Activation, SREBF1 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1402 |
228: demethylation, PPARg promoter |
1301: Activation, SREBP-1 |
Apr 12, 2017 |
Apr 12, 2017 |
None
|
| 1424 |
228: demethylation, PPARg promoter |
116: Activation, FAS |
Apr 13, 2017 |
Apr 13, 2017 |
None
|
| 1608 |
228: demethylation, PPARg promoter |
1028: Activation of specific nuclear receptors, PPAR-gamma activation |
Jul 24, 2017 |
Jul 24, 2017 |
1 AOP
|
| 1659 |
228: demethylation, PPARg promoter |
465: Increased, FA Influx |
Aug 31, 2017 |
Aug 31, 2017 |
1 AOP
|
| 2988 |
228: demethylation, PPARg promoter |
2165: Activation of PPAR |
Aug 20, 2023 |
Aug 20, 2023 |
1 AOP
|
| 1125 |
1086: persistent, cytotoxicity (pleura or peritoneum) |
1087: Increased, inflammation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1126 |
1086: persistent, cytotoxicity (pleura or peritoneum) |
1088: Increased, Oxidative Stress |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1377 |
1289: Perturbation of cholesterol |
1291: Hepatotoxicity |
Feb 15, 2017 |
Feb 15, 2017 |
1 AOP
|
| 2151 |
1794: Pin-1 activation |
1795: TGFbeta expression |
Jul 9, 2020 |
Jul 9, 2020 |
1 AOP
|
| 2456 |
1914: Platelet activation, Increased |
1857: Platelet-neutrophil interactions, Increased |
Aug 4, 2021 |
Aug 4, 2021 |
1 AOP
|
| 2458 |
1857: Platelet-neutrophil interactions, Increased |
1916: Thromboinflammation, Increased |
Aug 4, 2021 |
Aug 4, 2021 |
1 AOP
|
| 2070 |
1754: Porcupine-induced Wnt secretion and Wnt signaling activation |
1755: beta-catenin activation |
Mar 23, 2020 |
Nov 9, 2021 |
1 AOP
|
| 2607 |
1979: Premature differentiation |
1978: Microcephaly |
Mar 21, 2022 |
Mar 21, 2022 |
None
|
| 3107 |
1979: Premature differentiation |
2200: decline, neural progenitor cells |
Jan 10, 2024 |
Jan 10, 2024 |
1 AOP
|
| 1211 |
1146: premature, Spawning |
1164: Increased, Population |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1222 |
1146: premature, Spawning |
1141: Decreased, Reproductive Success |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1179 |
1144: premature, spawning 1 |
1141: Decreased, Reproductive Success |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1102 |
1064: prepubertal increase, Estrogen receptor (ER) activity |
1065: Activation, estrogen receptor alpha |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1283 |
1234: Production of nerve growth factor , Epithelial irritation |
1222: SP (Substance P) release, Local increase of SP |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1358 |
1274: Production of α-smooth muscle actin |
1276: Lung fibrosis |
Feb 15, 2017 |
Feb 15, 2017 |
None
|
| 93 |
77: Production, Critical Metabolites (CGA 330050 and CGA 265307) |
164: Induction, Liver “Dysfunctional” Changes by CGA 330050 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 276 |
249: Production, Reactive oxygen species |
209: Peptide Oxidation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|